When generics turn into Big Pharma

Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims  

Effectiveness of COVID-19 vaccines against infection, severe disease declined with new variants; here's how

AstraZeneca vaccine provided least protection against infection, showed most rapid decline

Pandemic treaty: Draft urges cooperation, equity, transparency but misses independent monitoring

Draft has evolved from a working document circulated earlier this year in July and builds on the comments made by member states, domain experts …

Moderna strikes with a new lawsuit

Moderna is trying to be gatekeeper for the mRNA platform for future drug development, raising monopolistic fears

Experts suggest updating vaccines for new variants. How does it work & what are the challenges?

It is easier to update certain vaccine platforms than others, say experts

Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA

Unclear which combination of updated vaccine will work best; body expected to decide by July

Charity after profiteering, the Big Pharma way

Pfizer to sell its medicines at no profit in world’s poorest countries, and other big names to make cancer drugs more accessible

Making COVID-19 vaccines in Africa: Advances and sustainability issues

Demand, market for locally produced vaccines critical for sustainability of 15 COVID-19 vaccines manufacturing facilities

COVID-19 surge: Why has China not attained herd immunity despite high vaccination coverage?

Germany, South Korea, Vietnam are also reporting increase in COVID-19 cases despite extensive vaccination

COVID-19: How is expiration date of vaccines determined?

Expired vaccines are not particularly unsafe or dangerous, say experts

Viva Cuba for its vaccine revolution

Punching way above its weight, the tiny nation has developed five vaccines, and offers hope of vaccine equity across the world    

COVID-19: Has Big Pharma enabled the rise of omicron

Major drug companies do not want to share the know-how for their vaccines; uneven global vaccine access is now resulting in …

Global COVID-19 cases set to triple with over 3 billion omicron infections in coming 2-3 months: IHME

Australia and New Zealand may experience their worst outbreaks of this pandemic

Omicron may already be in most countries, WHO warns

People dismissing omicron infection as mild may fuel spread, says WHO

COVID-19: Pfizer, AstraZeneca efficacy significantly reduced against omicron, says UK health agency 

Omicron is displaying growth advantage over delta and is poised to become dominant variant in UK

Omicron can partially evade vaccines, booster dose needed : Studies

Vaccinated persons who had contracted COVID-19 in the past have better protection against the disease  

Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: What’s known so far

Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines

How Rwanda reached first global COVID-19 vaccination target

Rwanda defined a vaccination plan prior to getting the vaccines

Lateral thoughts: COVID-19 vaccines and a game of chance

Would you be compensated for adverse reactions to the COVID-19 vaccines?  

Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth

Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …

Trade barriers, raw material scarcity can dent hopes for 10 billion COVID-19 vaccines in production

Experts warned of short supply of crucial raw materials; late delivery of bio-reactor giant plastic bags can set back production by weeks, …

New Delta+ variant found in India can escape antibodies

Mutations in the Delta+ variant can render vaccines and treatments ineffective

WATCH: Will mixing COVID-19 vaccines be effective?

Some early studies have shown that combining vaccines produce a better immune response. But the efficacy of the vaccine combination is yet to be …

Vaccines work just fine without side effects says a new Lancet study

Only one in four people experience mild, short-lived systemic side-effects after receiving either the Pfizer Inc or the Oxford University-…

COVID-19 in Africa: The pain of getting the jab

The COVAX Facility and the African Union are struggling to bring some relief to Africa which has been suffering from vaccine apartheid